Expression and Function of Transferrin Receptor 2 in the Hematopoietic Systems.

转铁蛋白受体 2 在造血系统中的表达和功能。

基本信息

  • 批准号:
    13671088
  • 负责人:
  • 金额:
    $ 1.6万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

Background : During the term of this project, it was reported by others that homozygous mutations of transferrin receptor 2 (TfR2) cause hemochromatosis type 3. Homozygous TfR2-mutated mice created in collaboration with Philip Koeffler (UCLA/Cedars-Sinai Medical Center) and Robert Fleming (Saint Louis University) exhibited iron accumulation in the liver, a similar phenotype to hemochromatosis. These findings demonstrated that TfR2 is involved in iron metabolism. In this study, I focused on the expression and function of TfR2 in hematopoietic cells.Methods and Results : First; I made two polyclonal antibodies against TfR2, using either TfR2 protein produced in bacteria or a TfR2 synthetic peptide as antigens. Specificities and sensitivities of these antibodies were tested using CHO-TRVb cells stably transfected with TfR2 or transferrin receptor 1 expression plasmids. These antibodies were useful for immunohistochemistry and Western blot analysis. Additionally, I established a sandwich ELISA system for detecting soluble forms of TfR3. Significant levels of TfR2 in the human serum samples could not be detected, indicating that the quantity of soluble TfR2 in the serum may be low. Next, I examined expression of TfR2 in bone marrow (BM) cells by immunohistochemistry. Most erythroid cells showed positive staining, while most myeloid cells were negative. One erythroleukemia sample showed very strong staining for TfR2. I analyzed the homozygous TfR2-mutated mice. Cell counts and morphologies of the both BM and peripheral blood cells were normal. Colony counts of CFU-GM, BFU-E and CFU-Meg of the BM of these mice were also normal.Discussion : Recent reports indicate that hepcidin, a hepatic peptide hormone, plays an essential role in iron homeostasis. I am now working on the relationship between hepcidin and TfR2, which may be the sensor for iron-transferrin in liver. Also, the significance of expression of TfR2 in erythroleukemia cells remains to be determined.
背景资料:在本项目期间,其他人报道转铁蛋白受体2(TfR 2)的纯合突变导致3型血色病。与Philip Koeffler(加州大学洛杉矶分校/Cedars-Sinai医学中心)和Robert Fleming(圣刘易斯大学)合作创建的纯合子TfR 2突变小鼠显示出肝脏中的铁积累,这与血色素沉着症相似。这些发现表明TfR 2参与铁代谢。本研究主要研究TfR 2在造血细胞中的表达和功能。方法和结果:首先,以细菌产生的TfR 2蛋白和TfR 2合成肽为抗原,制备了两株TfR 2多克隆抗体。这些抗体的特异性和灵敏度使用稳定转染有TfR 2或转铁蛋白受体1表达质粒的CHO-TRVb细胞进行测试。这些抗体可用于免疫组织化学和Western印迹分析。此外,我建立了一个夹心ELISA系统,用于检测可溶性形式的TfR 3。在人血清样品中未检测到显著水平的TfR 2,表明血清中可溶性TfR 2的量可能较低。接下来,我通过免疫组织化学检测了TfR 2在骨髓(BM)细胞中的表达。多数红系细胞呈阳性染色,而多数髓系细胞呈阴性染色。一个红白血病样品显示出非常强的TfR 2染色。我分析了纯合子TfR 2突变小鼠。骨髓和外周血细胞的细胞计数和形态均正常。这些小鼠骨髓的CFU-GM、BFU-E和CFU-Meg的集落计数也是正常的。讨论:最近的报道表明,铁调素,一种肝肽激素,在铁稳态中起着至关重要的作用。我现在正在研究铁调素和TfR 2之间的关系,TfR 2可能是肝脏铁转铁蛋白的传感器。此外,TfR 2在红白血病细胞中表达的意义仍有待确定。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kawabata H, Nakamaki T, Ikonomi P, Smith RD, Germain RS, Koeffler HP: "Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells"BLOOD. 68. 2712-2717 (2001)
Kawabata H、Nakamaki T、Ikonomi P、Smith RD、Germain RS、Koeffler HP:“转铁蛋白受体 2 在正常和肿瘤造血细胞中的表达”BLOOD。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fleming RE, Ahmann JR, Migas MC, Waheed A, Koeffler HP, Kawabata H, Britton RS, Bacon BR, Sly WS: "Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis"Proc Natl Acad Sci USA. 99. 10653-10658 (2002)
Fleming RE、Ahmann JR、Migas MC、Waheed A、Koeffler HP、Kawabata H、Britton RS、Bacon BR、Sly WS:“鼠转铁蛋白受体 2 基因的定向诱变产生血色素沉着症”Proc Natl Acad Sci USA。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kawabata H, Nakamaki T, Ikonomi P, Smith RD, Germain RS, Koeffler HP: "Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells"BLOOD. 98. 2712-2717 (2001)
Kawabata H、Nakamaki T、Ikonomi P、Smith RD、Germain RS、Koeffler HP:“转铁蛋白受体 2 在正常和肿瘤造血细胞中的表达”BLOOD。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAWABATA Hiroshi其他文献

KAWABATA Hiroshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAWABATA Hiroshi', 18)}}的其他基金

Near-trench magmatism and its thermal effects on accretionary sediments
近海沟岩浆作用及其对增生沉积物的热效应
  • 批准号:
    18K03783
  • 财政年份:
    2018
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Crosstalk between erythropoiesis and iron homeostasis
红细胞生成和铁稳态之间的串扰
  • 批准号:
    26461400
  • 财政年份:
    2014
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulatory mechanisms of hepcidin, the central regulator of body iron homeostasis
铁调素(体内铁稳态的中央调节剂)的调节机制
  • 批准号:
    22591033
  • 财政年份:
    2010
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Melt segregation from highly crystallized magmas under simple shear
简单剪切下高度结晶岩浆的熔体分离
  • 批准号:
    20740310
  • 财政年份:
    2008
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Impaired Iron Metabolism in Anemia of Chronic Disease
慢性病贫血铁代谢受损
  • 批准号:
    19591107
  • 财政年份:
    2007
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Significance of the mechanisms of iron homeostasis in malignancies and inflammatory diseases.
铁稳态机制在恶性肿瘤和炎症性疾病中的意义。
  • 批准号:
    17591016
  • 财政年份:
    2005
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Regulation of hepatic hepcidin expression by transferrin receptor-2
转铁蛋白受体2对肝脏铁调素表达的调节
  • 批准号:
    10673689
  • 财政年份:
    2021
  • 资助金额:
    $ 1.6万
  • 项目类别:
Regulation of hepatic hepcidin expression by transferrin receptor-2
转铁蛋白受体2对肝脏铁调素表达的调节
  • 批准号:
    10302636
  • 财政年份:
    2021
  • 资助金额:
    $ 1.6万
  • 项目类别:
Development of novel method for visualizing fish spermatogonia using transferrin receptor
开发利用转铁蛋白受体可视化鱼类精原细胞的新方法
  • 批准号:
    21K19138
  • 财政年份:
    2021
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Innovative Transferrin Receptor Regulation Mechanisms via Rare Modifications
通过罕见修饰实现创新的转铁蛋白受体调节机制
  • 批准号:
    21K15044
  • 财政年份:
    2021
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Regulation of hepatic hepcidin expression by transferrin receptor-2
转铁蛋白受体2对肝脏铁调素表达的调节
  • 批准号:
    10471318
  • 财政年份:
    2021
  • 资助金额:
    $ 1.6万
  • 项目类别:
A Brain Penetrating Bi-functional Transferrin Receptor Antibody-TNF-alpha Decoy Receptor Fusion Protein for Alzheimer's Disease
用于治疗阿尔茨海默病的脑穿透双功能转铁蛋白受体抗体-TNF-α诱饵受体融合蛋白
  • 批准号:
    10397273
  • 财政年份:
    2019
  • 资助金额:
    $ 1.6万
  • 项目类别:
A Brain Penetrating Bi-functional Transferrin Receptor Antibody-TNF-alpha Decoy Receptor Fusion Protein for Alzheimer's Disease
用于治疗阿尔茨海默病的脑穿透双功能转铁蛋白受体抗体-TNF-α诱饵受体融合蛋白
  • 批准号:
    10468923
  • 财政年份:
    2019
  • 资助金额:
    $ 1.6万
  • 项目类别:
A Brain Penetrating Bi-functional Transferrin Receptor Antibody-TNF-alpha Decoy Receptor Fusion Protein for Alzheimer's Disease
用于治疗阿尔茨海默病的脑穿透双功能转铁蛋白受体抗体-TNF-α诱饵受体融合蛋白
  • 批准号:
    10615185
  • 财政年份:
    2019
  • 资助金额:
    $ 1.6万
  • 项目类别:
Understanding the Interaction Between Transferrin Receptor 1 and the Iron Hormone Hepcidin in Liver Iron Metabolism
了解转铁蛋白受体 1 与铁激素铁调素在肝脏铁代谢中的相互作用
  • 批准号:
    386316
  • 财政年份:
    2017
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Studentship Programs
The role of soluble transferrin receptor in the regulation of iron homeostasis
可溶性转铁蛋白受体在铁稳态调节中的作用
  • 批准号:
    nhmrc : 1051764
  • 财政年份:
    2013
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了